Activity Profile of an FDA-Approved Compound Library against Schistosoma mansoni.
BACKGROUND:As plans to expand mass drug treatment campaigns to fight schistosomiasis form, worries about reliance on praziquantel as the sole available treatment motivate the investigation for novel antischistosomal compounds. Drug repurposing might be an inexpensive and effective source of novel an...
Saved in:
Main Authors: | Gordana Panic (Author), Mireille Vargas (Author), Ivan Scandale (Author), Jennifer Keiser (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the Schistosoma mansoni mouse model.
by: Nada Abla, et al.
Published: (2017) -
Screening of an FDA-Approved Library for Novel Drugs against <i>Y. pestis</i>
by: David Gur, et al.
Published: (2021) -
Onchocerciasis Drug Discovery: In Vitro Evaluation of FDA-Approved Drugs against <i>Onchocerca gutturosa</i> in Gambia
by: Suzanne Gokool, et al.
Published: (2024) -
FDA approved injection drug against schizophrenia
by: article Editorial
Published: (2023) -
In Vitro Screening of a 1280 FDA-Approved Drugs Library against Multidrug-Resistant and Extensively Drug-Resistant Bacteria
by: Lucie Peyclit, et al.
Published: (2022)